Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
1.980
-0.030 (-1.49%)
Nov 21, 2024, 3:21 PM EST - Market open
Can-Fite BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 14 | 9 | 19 | 39 | 29 | 13 | |
| Market Cap Growth | 16.31% | -54.62% | -49.45% | 34.30% | 121.58% | -48.36% | |
| Enterprise Value | 10 | 0 | 9 | 24 | 18 | 8 | |
| Last Close Price | 2.01 | 2.20 | 6.13 | 12.90 | 17.80 | 33.00 | |
| PS Ratio | 22.43 | 11.90 | 24.06 | 45.20 | 37.63 | 6.38 | |
| PB Ratio | 6.03 | 1.42 | 4.36 | 2.68 | 4.73 | 5.31 | |
| P/TBV Ratio | 6.03 | 1.42 | 4.36 | 2.68 | 4.73 | 5.31 | |
| EV/Sales Ratio | 14.35 | 0.65 | 10.63 | 28.70 | 23.35 | 4.00 | |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | |
| Asset Turnover | 0.08 | 0.08 | 0.05 | 0.06 | 0.09 | 0.25 | |
| Quick Ratio | 2.38 | 4.42 | 3.19 | 7.01 | 6.57 | 1.04 | |
| Current Ratio | 2.93 | 4.90 | 3.66 | 7.35 | 7.41 | 2.18 | |
| Return on Equity (ROE) | -157.62% | -142.49% | -107.91% | -123.34% | -339.20% | -462.71% | |
| Return on Assets (ROA) | -57.46% | -53.15% | -42.73% | -53.91% | -99.87% | -93.07% | |
| Return on Capital (ROIC) | -102.80% | -94.70% | -66.28% | -77.75% | -204.13% | -271.31% | |
| Earnings Yield | -51.54% | -86.33% | -52.20% | -32.72% | -50.31% | -97.45% | |
| FCF Yield | -51.98% | -95.47% | -55.47% | -25.60% | -42.11% | -85.57% | |
| Buyback Yield / Dilution | -57.39% | -56.71% | -47.49% | -54.31% | -317.19% | -120.84% | |
| Total Shareholder Return | -57.39% | -56.71% | -47.49% | -54.31% | -317.19% | -120.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.